Raju Mohan
CHIEF EXECUTIVE OFFICER AND DIRECTOR
Board of Director
Akarna Therapeutics
India
Biography
Raju is a co-founder of Akarna and has served as our Chief Executive Officer since January 2016 and a member of our board of directors since November 2014. Prior to Akarna, Raju co-founded Alexar Therapeutics in 2014, a dermatology-focused specialty pharmaceutical company. From 2006 to 2011, he served as Vice President and head of the San Diego site for Exelixis and Vice President of Chemistry at X-Ceptor Therapeutics (acquired by Exelixis). Raju started his pharmaceutical career at Berlex Biosciences, a subsidiary of Bayer/Schering AG where he held positions of increasing responsibility. Raju is responsible for the discovery of multiple small-molecule candidates that have entered clinical trials, including a FXR agonist and other nuclear receptor drugs. He has published extensively in peer-reviewed journals and is an inventor on 50 issued US patents. Raju received his Ph.D. in Chemistry from the University of Illinois and his Master’s degree from the Indian Institute of Technology.
Research Interest
Chemistry, Pharmaceutical Science
